论文信息 - CD19 Cell Count at Baseline Predicts B Cell Repopulation at 6 and 12 Months in Multiple Sclerosis Patients Treated with Ocrelizumab - 字舞流文

CD19 Cell Count at Baseline Predicts B Cell Repopulation at 6 and 12 Months in Multiple Sclerosis Patients Treated with Ocrelizumab

G. Marfia | D. Landi | P. Cavalla | S. Bonavita | L. Lavorgna | P. Valentino | M. Sparaco | M. Vercellino | G. Lus | E. Signoriello | G. Miele | G. Abbadessa | C. Bosa | A. De Martino | Rosanna Missione